by Frank Grimsey Jones | Aug 21, 2021 | Health economic modelling, Market access
Insights Health economic modelling: a guide for pharmaceutical and medical device companies Health economic modelling is a process for synthesising and comparing the costs and benefits of new (proposed) and existing medicines or devices in order to make decisions...
by Kristen Markus | Aug 13, 2021 | Clinical trial, Evidence generation, Health outcomes, Market access, Medical affairs
Insights Evidence generation and communication in drug development Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease processes and progression. This rapidly evolving knowledge...
by Kristen Markus | Aug 13, 2021 | Evidence synthesis, Health outcomes, Healthcare, Market access
Insights Evidence synthesis for healthcare decision-making What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision makers must continuously re-evaluate the evidence base that...
